Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Gastric Ulcers Therapeutics Report 2016: Pipeline Review of 5 Companies & 7 Molecules - Research and Markets

Research and Markets
Posted on: 20 Oct 16

Research and Markets has announced the addition of the "Gastric Ulcers - Pipeline Review, H2 2016" report to their offering.

'Gastric Ulcers - Pipeline Review, H2 2016' Gastric Ulcers pipeline therapeutics constitutes close to 7 molecules, out of which approximately 7 molecules are developed by Companies.

Furthermore, the publisher says, Gastric ulcer is a painful sore or ulcer in the lining of the stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or vomiting and unexplained weight loss. Predisposing factors include smoking and alcoholism. Treatment includes antibiotics and antacids.

'Gastric Ulcers - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Gastric Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, that are being developed by Companies / Universities.

It also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 4 and 1 respectively.

Key Topics Covered:

  1. Introduction
  2. Gastric Ulcers Overview
  3. Therapeutics Development
  4. Pipeline Products for Gastric Ulcers - Overview
  5. Pipeline Products for Gastric Ulcers - Comparative Analysis
  6. Gastric Ulcers - Therapeutics under Development by Companies
  7. Gastric Ulcers - Therapeutics under Investigation by Universities/Institutes
  8. Gastric Ulcers Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Gastric Ulcers - Products under Development by Companies
  13. Gastric Ulcers - Products under Investigation by Universities/Institutes
  14. Gastric Ulcers - Companies Involved in Therapeutics Development
  • Ache Laboratorios Farmaceuticos S/A
  • Astellas Pharma Inc.
  • ChoDang Pharm Co., Ltd.
  • Kukje Pharmaceutical Industry Co., Ltd.
  • XuanZhu Pharma Co., Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/6mqkpn/gastric_ulcers

View source version on businesswire.com: http://www.businesswire.com/news/home/20161020006437/en/

Business Wire
www.businesswire.com

Last updated on: 20/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.